Crossject signs a geographic extension of ZEPIZURE® commercialization agreement in Europe
GlobeNewswire
Extended contract now covers a total of 11 European countries
Crossject will receive milestone payments of up to €1..
Extended contract now covers a total of 11 European countries
Crossject will receive milestone payments of up to €1..
· Increase in visibility in its regulatory and commercialization prospects in the U.S. since latest interactions with the..
Dijon, February 27, 2024 at 8:30am
*Crossject obtains a financing up to €12 million, in two tranches,*
*from an..